Background-T lymphocytes are thought to be important in atherosclerosis, but very little is known about the mechanisms of lymphocyte recruitment into atherosclerosis-prone aortas. In this study we tested the hypothesis that CXCR6, a chemokine receptor that is expressed on a subset of CD4 ϩ T helper 1 cells and natural killer T cells, is involved in lymphocyte homing into the aortic wall and modulates the development and progression of atherosclerosis. Methods and Results-To investigate the role of CXCR6 in the development and progression of atherosclerosis, we bred CXCR6-deficient (CXCR6 GFP/GFP ) mice with apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice. We found that CXCR6
A therosclerotic lesions are characterized by lipid accumulation, cell death, fibrosis, and chronic vascular inflammation. 1 The body of evidence is growing that T and B lymphocytes, dendritic cells, and macrophages reside within the noninflamed aortic wall, and a significant influx of macrophages and T cells correlates with the development and progression of atherosclerosis. [2] [3] [4] The molecular mechanisms, kinetics of trafficking, and retention of different types of immune cells within the noninflamed and atherosclerosisprone aortic wall are not well defined. Most of the focus to date has been on the ability of monocytes to migrate to the atherosclerotic wall. 5 P-selectin, vascular cell adhesion molecule-1 (VCAM-1), P-selectin glycoprotein ligand-1 (PSGL-1), and ␣ 4 ␤ 1 integrin (VLA-4) are all involved in monocyte recruitment into atherosclerotic plaques, 6 and the chemokines CCL5 (regulated on activation, normal T cell expressed and secreted [RANTES] ) and CXCL1 (keratinocyte-derived chemokine [KC] ) are responsible for triggering monocyte adhesion on the atherosclerotic endothelium. [7] [8] [9] Lymphocyte trafficking into normal and atherosclerotic aortas is partially L-selectin dependent, 2 but little is known about other potential molecular mechanisms of lymphocyte recruitment.
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CXCR6 is a chemokine receptor expressed on some T helper 1 (Th1) and natural killer T (NKT) cells found in rheumatoid joints and inflamed livers. 10 CXCR6, also known as Bonzo/STRL33/TYMSTR, 11 is expressed on subpopulations of CD4 ϩ effector memory T cells, 10 on V␣ 24 ϩ NKT cells, 12, 13 a Forkhead Box P3 ϩ (Foxp3) subset (CD69 ϩ / CD45RO ϩ ) of regulatory T cells in the tonsils, 14 bone marrow plasma cells, and myeloma cells. 15 In mice, interstitial intraepithelial lymphocytes, NKT cells, 16 and memory subsets of CD8 ϩ and CD4 ϩ T cells express CXCR6, which is upregulated by interleukin-2 and interleukin-15 during short-term culture. 17 Recently, lipopolysaccharide-induced toll-like receptor 4 -dependent CXCR6 expression has been shown in aortic smooth muscle cells. 18 CXCL16 is the only known ligand for CXCR6 and is expressed by dendritic cells, 16 macrophages, 19 T cells, 20 and cytokine-stimulated smooth muscle and endothelial cells. 21, 22 The disintegrin and metalloproteinase ADAM10 is involved in CXCL16 cleavage from the cell membrane, 21 leading to the release of a soluble protein that functions as a chemoattractant for responsive leukocytes.
In addition to its properties as a chemokine, CXCL16 acts also as a scavenger receptor for apoptotic cells, phosphatidylserine, and oxidized low-density lipoprotein. 16, 19 Expression of CXCL16 has been reported in atherosclerosis-prone vessels from apolipoprotein-E-deficient (ApoE Ϫ/Ϫ ) mice 23 and human atherosclerotic plaques. 24 Absence of CXCL16 has been shown to accelerate atherosclerosis, enhance macrophage recruitment, and elevate mRNA levels for CCL2 (monocyte chemotactic protein-1) and tumor necrosis factor-␣. 25 Because the absence of CXCL16 results in the loss of scavenger function as well as chemotactic activity, inactivating the CXCL16 gene does not separate the roles of these 2 functions in atherosclerosis.
To investigate the involvement of the chemokine receptor CXCR6 in atherosclerosis, we crossed CXCR6-GFP knockin mice 17 to atherosclerosis-prone ApoE Ϫ/Ϫ mice. Because Th1 cells are thought to participate in the development of atherosclerosis, 26 we hypothesized that CXCR6, a receptor highly expressed on these cells, might be relevant for their trafficking into atherosclerotic vessel wall. In mice carrying 1 functional copy of CXCR6 (CXCR6 GFP/ϩ /ApoE Ϫ/Ϫ ) and mice that lack functional CXCR6 (CXCR6 GFP/GFP /ApoE Ϫ/Ϫ ), GFPexpressing cells were tracked by flow cytometry. Lesion size and composition were assessed by en face staining and aortic root histology. Homing of CXCR6 ϩ leukocytes was determined by flow cytometry. Functional consequences of CXCR6 cell recruitment were assessed as cytokine production and macrophage infiltration.
Methods

Mice
CXCR6
GFP/ϩ and CXCR6 GFP/GFP mice (backcrossed onto C57BL/6 Ͼ8 generations, 98.18% of C57BL/6 [microsatellite marker screening, Charles River Lab]) were a kind gift of Dr Littman (Howard Hughes Medical Institute, New York University). ApoE Ϫ/Ϫ mice (C57BL/6 background) were purchased from Jackson Laboratories (Bar Harbor, Maine) and crossed with CXCR6 knockin mice to obtain CXCR6 GFP/ϩ /ApoE Ϫ/Ϫ and CXCR6
GFP/GFP /ApoE Ϫ/Ϫ mice. Mice were bred and maintained under specific pathogen-free conditions in the barrier of the University of Virginia, Charlottesville. Mice appeared healthy and were used at ages 8 to 60 weeks. All animal experiments were approved by the institutional Animal Care and Use Committee.
Preparation of Mouse Aortas and Quantification of Atherosclerosis
The aortas of mice were collected and stained with oil red O. 27 Images were scanned, and the percent surface areas occupied by lesions were determined with Image-ProPlus (Media Cybernetics). From the point of the appearance of aortic valve leaflets, sequential 5-m-thick sections were cut, and 4 sections Ͼ300 m were collected and analyzed by Movat staining. 28 
Flow Cytometry Analysis of Immune Cells Within Murine Aorta
Anesthetized mice were perfused by cardiac puncture with PBS containing 20 U/mL of heparin. Harvested aortas were digested with 125 U/mL collagenase type XI, 60 U/mL hyaluronidase type I-s, 60 U/mL DNAse1, and 450 U/mL collagenase type I (all enzymes, Sigma, St Louis, Mo) in PBS containing 20 mmol/L HEPES at 37°C for 1 hour. 2 A cell suspension was obtained by mashing the aorta through a 70-m strainer. Cells were incubated with antibodies for 20 minutes at 4°C, washed twice, and incubated with secondary antibodies for an additional 20 minutes. After they were washed, immunofluorescence was detected by flow cytometry (FACSCalibur, BD Immunocytometry Systems, San Jose, Calif) or CyanADP (Dako, Colo), and data were analyzed with the use of FlowJO (Tree Star Inc, Ashland, Ore) software. PE-Texas Red-CD45, APC-Cy7 or Pe-Cy5-CD3, APC-TCR␤, PE-I-A b , NK1.1-APC, CD62L-APC, Ly6C-biotin antibodies, and streptavidin-Per-CP, APC-Cy7 were from BD Biosciences, San Jose, Calif; CD115-PE from eBioscience (San Diego, Calif); Pacific Blue-CD11b and streptavidin-PE-Texas Red from Caltag (Burlingame, Calif); and FITC-CD68 from Serotec, Raleigh, NC. Biotin-conjugated anti-rat and anti-hamster antibodies were from Vector Laboratories, Inc (Burlingame, Calif). CCR2 antibody was kindly provided by M. Mack (University of Regensburg, Germany). In some experiments, the aortas from 2 to 3 mice were pooled and analyzed. 
In Vivo Trafficking Experiments
Detection of Cytokine Production Within the Aortic Wall
Dissected aortas were chopped into small pieces and placed in 100 L of PBS at 37°C. After 10 minutes, supernatants were collected and cytokines were detected according to the BD Cytometric Bead Array protocol.
Immunohistochemistry
Paraformaldehyde-fixed cryosections of aortic root from ApoE Ϫ/Ϫ mice were incubated with a monoclonal antibody to CXCR6 (R&D, Minneapolis, Minn), antibody to CXCL16 (R&D), or respective isotype controls. Cell type-specific expression of the cryosections was characterized by costaining for Moma-2 (Serotec, Raleigh, NC) and ␣-smooth muscle actin (Dako, Hamburg). Next, secondary antibodies with FITC and TRITC-coupled reagents (Sigma-Aldrich, St Louis, Mo) were used. Paraformaldehyde-fixed paraffin sections of human carotid endarterectomy specimens were incubated with a monoclonal antibody to CXCR6 or CXCL16 followed by FITCcoupled secondary antibodies and costained for F4/80 (Serotec), ␣-smooth muscle actin (Dako, Hamburg), or CD3 (Serotec) with the use of TRITC-coupled reagents. Nuclei were counterstained with DAPI. Paraformaldehyde-fixed paraffin sections of murine aortic root were stained with Movat pentachrome 28 or with monoclonal antibody to Mac-2 (Cedarlane Laboratory, Limited) and hematoxylin.
Statistical Analysis
Data are represented as meanϮSE. Comparisons were made with the use of the unpaired Student test or Mann-Whitney test as appropriate.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
CXCR6 Deficiency Diminishes the Development of Atherosclerosis in CXCR6
GFP/GFP /ApoE ؊/؊ Mice At 54 to 56 weeks of age, CXCR6
GFP/GFP /ApoE Ϫ/Ϫ and ApoE Ϫ/Ϫ mice on a chow diet had comparable body weight and levels of total plasma cholesterol, high-density lipopro- Figure 1C ). The percentage of plaque area within the aortic roots of 41-week-old mice fed a chow diet was decreased by 22% in CXCR6 GFP/GFP /ApoE Ϫ/Ϫ mice compared with ApoE Ϫ/Ϫ mice ( Figure 1D and 1E). We also found decreased macrophage content within the aortic root of CXCR6 GFP/GFP /ApoE Ϫ/Ϫ mice ( Figure 1D ). Partial deficiency of CXCR6 in CXCR6 GFP/ϩ /ApoE Ϫ/Ϫ mice had no effect on disease progression because the average lesion size in CXCR6 GFP/ϩ /ApoE Ϫ/Ϫ mice on a Western diet was not different from that in ApoE Ϫ/Ϫ mice (en face lesions: 13.5Ϯ1.7%). Taken together, these results suggest that CXCR6 is proatherogenic. Figure 3A ). The total number of CD45 ϩ leukocytes ( Figure 3A ) was similar in aortas of CXCR6 GFP/GFP /ApoE Ϫ/Ϫ and CXCR6 GFP/ϩ / ApoE Ϫ/Ϫ mice (0.68Ϯ0.11ϫ10 6 and 0.65Ϯ0.16ϫ10 6 per aorta, respectively). GFP ϩ leukocytes were found in the aortas of both heterozygous and CXCR6-deficient knockin mice ( Figure 3A) . However, the percentage of GFP ϩ leukocytes was significantly decreased in the aortas of CXCR6 GFP/ϩ /ApoE Ϫ/Ϫ mice ( Figure 3A, 3B ). Immunofluorescence of frozen sections of murine aortas showed colocalization of CXCR6 ϩ with CD3 ϩ T cells ( Figure 3C ) and with some Moma-2 ϩ macrophages ( Figure 3C ). No colocalization of CXCR6 with smooth muscle ␣-actin was present ( Figure  3C ). As expected, the CXCR6 ligand CXCL16 was expressed in most macrophages ( Figure 3C ). Confocal microscopy of murine atherosclerotic aortas confirmed colocalization of some Moma-2 ϩ cells with CXCR6 ( Figure 3D ). Flow cytometry analysis of the aortas of CXCR6 GFP/GFP /ApoE Ϫ/Ϫ and CXCR6 ϩ/GFP /ApoE Ϫ/Ϫ mice showed that Ϸ10% to 20% of CD115 ϩ /CD11b ϩ leukocytes expressed CXCR6 ( Figure 3E ). aortas using CMTMR labeling ( Figure 4A ). CXCR6 GFP/GFP / ApoE Ϫ/Ϫ (GFP ϩ /CMTMR ϩ ) lymphocytes showed impaired migration into the aortic wall compared with CXCR6 GFP/ϩ / ApoE Ϫ/Ϫ (GFP ϩ /CMTMR Ϫ ) lymphocytes (0.22Ϯ0.03% versus 0.55Ϯ0.12%, respectively; nϭ5) ( Figure 4B and 4E) . Although the absence of CXCR6 significantly reduced lymphocyte homing into the aortas, it did not change lymphocyte trafficking into the spleen (0.41Ϯ0.11% versus 0.39Ϯ0.10%; nϭ4) and PLN (0.16Ϯ0.05% versus 0.15Ϯ0.05%; nϭ4) for CXCR6 GFP/ϩ /ApoE Ϫ/Ϫ and CXCR6 GFP/GFP /ApoE Ϫ/Ϫ , respectively (Figure 4) .
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Reduced Number of CXCR6-Expressing T Lymphocytes in CXCR6-
Decreased Trafficking of CXCR6 GFP/GFP /ApoE
To provide further support for the role of CXCR6-expressing T lymphocytes in regulating the development and persistence of atherosclerosis, we evaluated the production of the Th1 cytokine interferon (IFN)-␥ and the Th2 cytokine interleukin-4 within the aortas. We found a significant reduction in IFN-␥ but not interleukin-4 production within the CXCR6 GFP/GFP /ApoE Ϫ/Ϫ aortas in comparison with the aortas of CXCR6 GFP/ϩ /ApoE Ϫ/Ϫ mice (Figure 5 ; nϭ8; PϽ0.05 by t test with Bonferroni correction for multiple comparison).
Reduction of Resident Aortic Macrophages in CXCR6
GFP/GFP /ApoE ؊/؊ Aortas
To investigate whether CXCR6 absence might alter monocyte and macrophage distribution, monocytes in blood and macrophages in PLN and spleen (data not shown) were examined for Ly6C expression. We found no difference in the percentage of CD115 ϩ /CD11b ϩ monocytes in blood of CXCR6 GFP/GFP /ApoE Ϫ/Ϫ and ApoE Ϫ/Ϫ mice (8.1Ϯ1.5% and 10.8Ϯ1.5%, respectively; nϭ11) ( Figure 6A 
/ApoE
Ϫ/Ϫ and ApoE Ϫ/Ϫ mice ( Figure 6C ).
Lack of CXCR6
ϩ T lymphocytes may curb IFN-␥ production within the aortas and thus may influence the recruitment or survival of monocytes. CD11b ϩ /CD68 ϩ macrophages were reduced by 90% ( Figure 6E ) in the aortas of CXCR6 GFP/GFP / ApoE Ϫ/Ϫ mice compared with CXCR6 GFP/ϩ /ApoE Ϫ/Ϫ mice (PϽ0.0005; nϭ8). The percentage of Ly6C high macrophages was also reduced within the aortas of CXCR6 GFP/GFP /ApoE Ϫ/Ϫ mice compared with ApoE Ϫ/Ϫ mice (6.8Ϯ1.5% versus 15.1Ϯ2.0%, respectively; PϽ0.05; nϭ4).
To address the potential importance of our findings for human atherosclerosis, the expression of CXCR6 and CXCL16 mRNA was investigated in carotid endarterectomy specimens versus nondiseased arteries by quantitative reverse transcription polymerase chain reaction, demonstrating 4-fold upregulation of both the chemokine and the receptor (data not shown). Sections from carotid endarterectomies were then stained for CXCR6 and CXCL16. Atherosclerotic plaques have few T cells, and most T cells reside under the media layer within tertiary lymphoid structures. 2 Therefore, only few T cells were detected within the plaques. CXCR6 was highly expressed in some CD3
ϩ T cells and F4/80 ϩ macrophages but not in smooth muscle cells ( Figure 7A ). CXCL16 mainly colocalized with macrophages ( Figure 7B ). Taken together with the mouse data, this suggests that the CXCR6/CXCL16 interaction plays an important role in atherosclerosis.
Discussion
This study reveals a significant proatherogenic role of CXCR6 in atherosclerosis. Absence of CXCR6 resulted in a Ϸ50% reduction in lesion formation as assessed by en face staining of the whole aorta and 22% of the lesion reduction within the aortic root. The decrease in lesion size was found in 56-week-old chow-fed mice and 25-week-old mice fed a Western diet. Removing 1 functional copy of CXCR6 had no effect. Flow cytometry analysis of aortas revealed a marked reduction in aortic GFP ϩ /CD3 ϩ but not NKT cells in CXCR6 GFP/GFP /ApoE Ϫ/Ϫ mice that was likely due to defective trafficking into the aortic wall. The decrease in the number of CXCR6 ϩ cells was accompanied by a reduction of aortic IFN-␥ production, one of the most powerful inflammatory cytokines that initiates and supports inflammation in the aorta. Even more notably, macrophages were decreased up to 90% in the aorta of CXCR6 GFP/GFP /ApoE Ϫ/Ϫ mice. Thus, CXCR6 is likely to be involved in atherosclerosis through the alteration of the homing of activated effector T cells into the aortas where those T cells produce proinflammatory cytokines, which determine macrophage recruitment.
T cells are abundant in the aortic adventitia of normal mice. 2, 3, 30 In atherosclerotic mice, some T cells are found in atherosclerotic plaque 31 and more in atherosclerosis-induced adventitial lymphoid structures. 2, 30 In the present study we describe a T-cell population that expresses CXCR6 and resides within the aortas of mice fed with either a chow or Western diet. Interestingly, the levels of CXCR6 expression and the percentage of GFP ϩ /CXCR6-expressing T cells from CXCR6 GFP/GFP /ApoE Ϫ/Ϫ mice were lower than in CXCR6
GFP/GFP mice. Adoptive transfer experiments suggest that the proinflammatory ApoE Ϫ/Ϫ environment reduces the levels of CXCR6 expression. CXCR6 expression is downregulated when T cells are stimulated via CD3/CD28 ligation. 32 The exact mechanism of CXCR6 downregulation remains to be determined, but one of the possible mechanisms might be downregulation secondary to T-cell receptor engagement.
Several studies have demonstrated an important role for chemokines and chemokine receptors in the recruitment of monocytes during atherosclerosis, but little is known about T-cell recruitment to the aortas. In the present study we provide evidence that CXCR6 is involved in the recruitment of Th1 cells into the aortic wall.
CXCL16 is the only known chemokine ligand for CXCR6 and plays a dual role as a chemokine and a scavenger receptor that binds oxidized low-density lipoprotein. Aslanian and Charo 25 generated CXCL16 Ϫ/Ϫ mice and showed that CXCL16 in vivo is atheroprotective. The present data suggest that this must be due to its scavenger receptor activity. Because CXCL16 deletion results in the abolishment of both CXCL16 functions (chemotaxis and scavenging), it is impossible to determine whether the chemokine or scavenger receptor function leads to the accelerated atherosclerosis in CXCL16 Ϫ/Ϫ mice. Shedding-resistant CXCL16 mutant mice might be useful to resolve this question. An alternative explanation for our finding is that CXCR6 may have additional ligand(s) that remain to be discovered.
The presence of NKT cells within atherosclerotic aortas and their proatherogenic role have been reported. 33 CXCR6 is broadly expressed on NKT cell populations in different organs such as the liver and spleen, 34 but the percentage of NKT cells expressing GFP in CXCR6-deficient mice is not different compared with control mice. Not only T cells but also a subset of macrophages expresses CXCR6 in atherosclerotic aortas. Further studies will be needed to determine the role of CXCR6 on macrophages. Interestingly, the absence of CXCR6 had no effect on the subpopulation of Ly6C high monocytes in the blood of CXCR6 GFP/GFP /ApoE Ϫ/Ϫ mice but resulted in the alteration of the number of Ly6C high CD11b ϩ /CD68 ϩ macrophages in the aorta, suggesting that the absence of CXCR6 alters the subsets of aortic macrophages residing within the aortic wall. CXCR6 ϩ T cells have a capacity to secrete a large amount of IFN-␥ on activation. 10, 35 In this study we show that CXCR6-deficient aortas secrete less IFN-␥, likely because of Figure 7 . CXCR6 is expressed by T cells in human atherosclerotic lesions. Sections of carotid endarterectomy specimens were costained for CXCR6 (A) or CXCL16 (B) and the cell type-specific markers. Colocalization (yellow) is shown in merged images, and counterstaining was performed with DAPI (blue). Except some autofluorescence of elastic laminae, isotype control staining was negative.
the decreased number of CXCR6 ϩ Th1 effector lymphocytes within the aortic wall. IFN-␥ is one of the key proinflammatory cytokines that participates in atherosclerosis and increases inflammatory aspects of this disease through upregulation of proinflammatory genes. 36 The decreased level of IFN-␥ in aortas of CXCR6-deficient mice might reduce macrophage recruitment. Indeed, we observed up to a 90% decrease of CD11b ϩ /CD68 ϩ M⌽ within the aortas of CXCR6-deficient mice. IFN-␥ also regulates the expression of CXCL10, CCL2, and CX3CL1, 36 which can further affect the recruitment of macrophages and T cells into the atherosclerotic aortic wall. It appears that CXCR6 ϩ T cells are an important source of IFN-␥ that regulates the cell content of atherosclerotic lesions.
In summary, the present study establishes CXCR6 as an important chemokine receptor in the development and progression of atherosclerosis through the recruitment of CXCR6 ϩ effector T cells into atherosclerotic aortas. Our findings suggest a new pathway by which effector T cells may influence the development of atherosclerosis through the alteration of immune composition within the aortic wall.
